Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/179800
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Udaondo, Patricia | - |
dc.contributor.author | Adán Civera, Alfredo | - |
dc.contributor.author | Arias Barquet, Lluís | - |
dc.contributor.author | Ascaso, Juan Francisco | - |
dc.contributor.author | Cabrera López, Francisco | - |
dc.contributor.author | Castro-Navarro, Verónica | - |
dc.contributor.author | Donate-López, Juan | - |
dc.contributor.author | García-Layana, Alfredo | - |
dc.contributor.author | Lavid, Francisco Javier | - |
dc.contributor.author | Rodríguez-Maqueda, Mariano | - |
dc.contributor.author | Ruiz Moreno, José María | - |
dc.date.accessioned | 2021-09-02T09:55:09Z | - |
dc.date.available | 2021-09-02T09:55:09Z | - |
dc.date.issued | 2021-07-01 | - |
dc.identifier.uri | http://hdl.handle.net/2445/179800 | - |
dc.description.abstract | Purpose: This paper aimed to present daily-practice recommendations for the management of diabetic macular edema (DME) patients based on available scientific evidence and the clinical experience of the consensus panel. Methods: A group of Spanish retina experts agreed to discuss different aspects related with the clinical management of DME patients. Results: Panel was mainly focused on therapeutic objectives in DME management; defini-tion terms; and role of biomarkers as prognostic and predictive factors to intravitreal treatment response. The panel recommends to start DME treatment as soon as possible in those eyes with a visual acuity less than 20/25 (always according to the retina unit capacity). Naive patient was defined, in a strict manner, as a patient who, up to that moment, had never received any treatment. A refractory DME patient may be defined as the one who did not achieve a complete resolution of the disease, regardless of the treatment administered. Different optical coherence tomography biomarkers, such as disorganization of the retinal inner layers, hyperreflective dots, and cysts, have been identified as prognostic factors. Conclusion: This document has sought to lay down a set of recommendations and to identify key issues that may be useful for the daily management of DME patients. | - |
dc.format.extent | 13 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Informa | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.2147/OPTH.S320948 | - |
dc.relation.ispartof | Clinical Ophthalmology, 2021, vol. 15, p. 3183-3195 | - |
dc.relation.uri | https://doi.org/10.2147/OPTH.S320948 | - |
dc.rights | cc by-nc (c) Udaondo, Patricia et al, 2021 | - |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/3.0/es/ | * |
dc.source | Articles publicats en revistes (Ciències Clíniques) | - |
dc.subject.classification | Complicacions de la diabetis | - |
dc.subject.classification | Retinopatia diabètica | - |
dc.subject.other | Diabetes complications | - |
dc.subject.other | Diabetic retinopathy | - |
dc.title | Challenges in Diabetic Macular Edema Management: An Expert Consensus Report | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedArticle | - |
dc.identifier.idgrec | 728977 | - |
dc.date.updated | 2021-08-05T08:32:51Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 34349495 | - |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
OPTH-320948-challenges-in-diabetic-macular-edema-management--an-expert-c.pdf | 2.78 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License